Meeting Manny and Simple Steps for Health

Yesterday I was fortunate to spend a few hours with Manny Hernandez, founder of TuDiabetes. Over lunch we talked about various efforts that underway to help folks with diabetes to improve their control.
Manny and David Edelman of DiabetesDaily are collaborating on a new site called
simple steps for health, and they're looking for input from
you.
They are asking you to submit simple ideas that make it easier to live with diabetes, and
simple is key. Your idea should not cost a lot or take much time to use.
You can submit these until the end of April (2009) and we can vote on them if you add a link to your submission.
Yes, there's some prizes, see the bottom of the
Simple Steps for Health page. But you may also help others with diabetes, and that has to be better than
any prize.
Labels: diabetes, Edwards Lifesciences, Manny, simple, steps
Edwards and Dexcom to develop CGM for Hospital Use
In news
announced recently,
Edwards Lifesciences is establishing a relationship with
Dexcom to develop CGM devices for use in hospital.
Dexcom has mentioned this possible market
in presentations over the last year, so this was an expected market development for them.
Edwards Lifesciences will pay an upfront fee of $13 million and follow up with further payments for product development based on meeting regulatory milestones.

Dexcom's CEO has
talked about a standalone Intensive Care Unit monitor in the past for in hospital use. But they also realize that the ICU is a crowded spaces and integrating the Dexcom system into existing equipment is important for product acceptance.
In intensive care, stress and other conditions means that patients' blood sugar control is often bad, even when they don't have diabetes. Tight glucose control leads to a faster recovery and better wound healing., leading to reduced costs and improved outcomes for patients. Currently about 25% of ICUs will try to do this using 12-24 fingersticks per 24 hours which costs a lot and keeps ICU staff busy. Using a CGM with programmable alarms leaves them with more time to care for patients.
In this agreement Edwards is responsible for sales and marketing. Given they already have a sales staff focused on the ICU market, this would be much more effective than growing an appropriate in-house staff at Dexcom. In return, Dexcom will receive a royalty of up to 7%.
For those of us, like myself, with Dexcom shares this might ultimately boost the share price which has been down substantially for some time now.
Labels: Dexcom, Edwards Lifesciences, ICU